Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD69 | Q07108 | 1/20 | 0.60 |
| ▸ | LGALS3 | P17931 | 6/20 | 0.60 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.60 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.60 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.50 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.50 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Acetylchitopentaose SCHEMBL20390680 | 1.00 | CD69 (0.60) | CD69LGALS3LGALS8LGALS4CHIA | |
| Chitodextrin SCHEMBL619917 | 1.00 | CD69 (0.60) | CD69LGALS3LGALS8LGALS4CHIA | |
| Triacetylchitotriose SCHEMBL425647 | 1.00 | CD69 (0.60) | CD69LGALS3LGALS8LGALS4CHIA | |
| Chitodextrin SCHEMBL19427436 | 1.00 | CD69 (0.60) | CD69LGALS3LGALS8LGALS4CHIA | |
| Chitodextrin SCHEMBL619918 | 1.00 | CD69 (0.60) | CD69LGALS3LGALS8LGALS4CHIA | |
| Triacetylchitotriose SCHEMBL13040980 | 1.00 | CD69 (0.60) | CD69LGALS3LGALS8LGALS4CHIA | |
| SCHEMBL20390674 | 1.00 | CD69 (0.60) | CD69LGALS3LGALS8LGALS4CHIA | |
| Chitodextrin SCHEMBL13046690 | 1.00 | CD69 (0.60) | CD69LGALS3LGALS8LGALS4CHIA | |
| Chitodextrin SCHEMBL21067311 | 1.00 | CD69 (0.60) | CD69LGALS3LGALS8LGALS4CHIA | |
| Chitodextrin SCHEMBL7269765 | 1.00 | CD69 (0.60) | CD69LGALS3LGALS8LGALS4CHIA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025032055-A1 | CYCLIC CARBAMATE COMPOUNDS FOR LIGATION | CARBOCALYX GMBH (DE) | 2025-02-13 | — | — | WO | claimed |
| EP-4081335-A2 | A NOVEL COMPOSITE MEMBRANE IN NANOFIBER FORM FOR SELECTIVELY SEPARATING ANIONIC AND CATIONIC ORGANIC COMPOUNDS, AND A PREPARATION METHOD THEREOF | Akdeniz Universitesi (TR) | 2022-11-02 | — | — | EP | claimed |
| WO-2021133332-A2 | A NOVEL COMPOSITE MEMBRANE IN NANOFIBER FORM FOR SELECTIVELY SEPARATING ANIONIC AND CATIONIC ORGANIC COMPOUNDS, AND A PREPARATION METHOD THEREOF | AKDENIZ UNIVERSITESI (TR) | 2021-07-01 | — | — | WO | claimed |
| WO-2011103144-A1 | METHODS AND SYSTEMS FOR DETECTION OF MICROBES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-08-25 | — | — | WO | claimed |
| US-5225543-A | RECEPTORS METHOD FOR PURIFICATION OF G PROTEIN-LINKED | AMERICAN CYANAMID COMPANY (US) | 1993-07-06 | — | — | US | claimed |
| US-12618852-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2026-05-05 | — | — | US | disclosed |
| US-12558448-B2 | Immobilized pH indicator for biological indicator growth indication | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-02-24 | — | — | US | disclosed |
| US-20260049992-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | AMBERGEN INC (US) | 2026-02-19 | — | — | US | disclosed |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250320255-A1 | UNIVERSAL ADJUVANT FOR NASAL, ORAL, AND INTRAMUSCULAR DELIVERY OF VACCINES | DESIGN ZYME LLC (US) | 2025-10-16 | — | — | US | disclosed |
| US-20250169516-A1 | METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-05-29 | — | — | US | disclosed |
| US-12268793-B2 | Liquid-chemical sterilization system with biological indicator | ASP GLOBAL MANUFACTURING GMBH (CH) | 2025-04-08 | — | — | US | disclosed |
| EP-0524173-A1 | SOLUBILIZATION AND PURIFICATION OF THE GASTRIN RELEASING PEPTIDE RECEPTOR. | BERLEX LAB (US) | 1993-01-27 | — | — | EP | disclosed |
| EP-0508221-A1 | Somatostatin receptor | AMERICAN CYANAMID COMPANY (US) | 1992-10-14 | — | — | EP | disclosed |
| WO-1992016623-A2 | RECEPTORS FOR BOMBESIN-LIKE PEPTIDES | BERLEX LABORATORIES, INC. (US) | 1992-10-01 | — | — | WO | disclosed |
| EP-0506032-A1 | Receptor purification method | AMERICAN CYANAMID COMPANY (US) | 1992-09-30 | — | — | EP | disclosed |
| EP-0497866-A1 | GASTRIN RELEASING PEPTIDE RECEPTOR | BERLEX LABORATORIES, INC. (US) | 1992-08-12 | — | — | EP | disclosed |
| WO-1991006647-A1 | GASTRIN RELEASING PEPTIDE RECEPTOR | TRITON BIOSCIENCES, INC. (US) | 1991-05-16 | — | — | WO | disclosed |
| WO-1991006646-A1 | SOLUBILIZATION AND PURIFICATION OF THE GASTRIN RELEASING PEPTIDE RECEPTOR | TRITON BIOSCIENCES, INC. (US) | 1991-05-16 | — | — | WO | disclosed |
| EP-0293931-A2 | Use of an alkaline phosphatase derivative as standard | Roche Diagnostics GmbH (DE) | 1988-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12558448-B2 | Immobilized pH indicator for biological indicator growth indication | ALPG, GUSB, HAO2 | CD69 310/4885LGALS3 2292/4885LGALS8 1668/4885 |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | CD69 3741/4885LGALS3 66/4885LGALS8 264/4885 |
| US-20260049992-A1 | NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBES | MKI67, CD44, MUC1 | CD69 477/4885LGALS3 28/4885LGALS8 63/4885 |
| US-12618852-B2 | Photocleavable mass-tags for multiplexed mass spectrometric imaging of tissues using biomolecular probes | CD44, CD68, EPCAM | CD69 1081/4885LGALS3 25/4885LGALS8 55/4885 |
| US-20250320255-A1 | UNIVERSAL ADJUVANT FOR NASAL, ORAL, AND INTRAMUSCULAR DELIVERY OF VACCINES | B3GNT2, ST3GAL3, MUC1 | CD69 157/4885LGALS3 112/4885LGALS8 225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.